President, North America Region · PHIBRO ANIMAL HEALTH CORP (PAHC)

Rob Aukerman

A named executive officer of PHIBRO ANIMAL HEALTH in every fiscal year CompBrief holds from FY2020 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$619,272

Salary $484,828Bonus $38,780

FY2022: $807,440

3rd of 5 named executive officers at Phibro Animal Health by FY2023 total.

5 named officers on file for PHIBRO ANIMAL HEALTH, FY2023

Rob Aukerman’s pay file — $29

  • 4 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how PHIBRO ANIMAL HEALTH’s whole pay program stands against its peers

  • PHIBRO ANIMAL HEALTH’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on PAHC→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed September 15, 2023 (DEF 14A).

Free

Get Rob Aukerman’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Rob Aukerman compensation by year

PHIBRO ANIMAL HEALTH Summary Compensation Table · all 4 fiscal years held
In US dollars, as PHIBRO ANIMAL HEALTH reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021FY2022FY2023
Salary$450,000$450,000$463,950$484,828
Bonus$0$0$105,000$38,780
Stock awards$0———
Option awards$0———
Non-equity incentive$104,400$214,800$194,950$50,150
Pension and deferred compensation$0$0$0$0
All other$51,479$37,717$43,540$45,514
Total$605,879$702,517$807,440$619,272

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: PHIBRO ANIMAL HEALTH CORP DEF 14A filed September 15, 2023, accession 0001558370-23-015820, and prior-year filings. Open the filing on EDGAR.

How this page was built: the PHIBRO ANIMAL HEALTH CORP filed document, accession 0001558370-23-015820. Every figure is read from that document and cited to the page and table it appears in. Filed September 15, 2023.

$606K
$703K
$807K
$619K
FY20
FY21
FY22
FY23
SalaryBonusNon-equity incentiveAll other

PHIBRO ANIMAL HEALTH’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Jack BendheimChairman of the Board, President, and Chief Executive Officer$2,938,899
Larry MillerChief Operating Officer$778,803
Rob Aukerman · this pagePresident, North America Region$619,272
Damian FinioChief Financial Officer$567,461
Daniel BendheimDirector and Executive Vice President, Corporate Strategy$554,690

The full PHIBRO ANIMAL HEALTH compensation record

free company brief

This page is one person within PHIBRO ANIMAL HEALTH's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are PHIBRO ANIMAL HEALTH's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Rob Aukerman's compensation dossier · One-time report. No refunds.